CellPhire

    OverviewSuggest Edit

    CellPhire is a biotechnology company focusing on cell stabilization technology with an emphasis on blood platelets. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets. The company develops products that have potential applications in health care fields from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.
    TypePrivate
    Founded2005
    HQRockville, MD, US
    Websitecellphire.com

    Latest Updates

    Employees (est.) (Jul 2021)43(+8%)
    Cybersecurity ratingBMore

    Key People/Management at CellPhire

    Rafael Jorda

    Rafael Jorda

    Executive Vice President
    G. Michael Fitzpatrick

    G. Michael Fitzpatrick

    President
    Keith A. Moskowitz

    Keith A. Moskowitz

    Vice President of Discovery
    Thomas S. Dann

    Thomas S. Dann

    Chief Investment Officer
    Show more

    CellPhire Office Locations

    CellPhire has an office in Rockville
    Rockville, MD, US (HQ)
    9430 Key W Ave
    Show all (1)

    CellPhire Financials and Metrics

    Summary Metrics

    Founding Date

    2005

    CellPhire Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    82/100

    SecurityScorecard logo

    CellPhire Online and Social Media Presence

    Embed Graph

    CellPhire News and Updates

    Cellphire Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Thrombosomes in Bleeding Thrombocytopenic Patients

    ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that the first patient has been dosed in the company's...

    Cellphire President G. Michael Fitzpatrick Awarded Armed Services Program Lifetime Achievement Award

    ROCKVILLE, Md., Sept. 23, 2020 /PRNewswire/ -- Cellphire, the global leader in long-term stabilization and storage of platelets, is proud to announce that the Armed Services Blood Program (ASBP) has awarded Cellphire President G. Michael Fitzpatrick, PhD, with the 2020 ASBP Lifetime...

    Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients

    ROCKVILLE, Md., March 18, 2020 /PRNewswire/ -- Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to start a Phase 2 clinical trial of Thrombosomes in...

    CellPhire Frequently Asked Questions

    • When was CellPhire founded?

      CellPhire was founded in 2005.

    • Who are CellPhire key executives?

      CellPhire's key executives are Rafael Jorda, G. Michael Fitzpatrick and Keith A. Moskowitz.

    • How many employees does CellPhire have?

      CellPhire has 43 employees.

    • Who are CellPhire competitors?

      Competitors of CellPhire include Viracor Eurofins, Progenity and Epic Sciences.

    • Where is CellPhire headquarters?

      CellPhire headquarters is located at 9430 Key W Ave, Rockville.

    • Where are CellPhire offices?

      CellPhire has an office in Rockville.

    • How many offices does CellPhire have?

      CellPhire has 1 office.